The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Decitabine is also known as 5 - nitrogen hetero - 2 '- DNA cytosine nucleoside, 5 - n - 2' - deoxy cytidine acid, is a kind of natural 2 '- deoxy cytidine acid adenosine analogues, by inhibiting the DNA methyltransferase, reduce DNA methylation, thus inhibiting tumor cell proliferation, and prevent the occurrence of drug resistance, for the strongest known DNA methylation specific inhibitor, belongs to the S phase of cell cycle specific drugs, is suitable for the treatment of myelodysplastic syndrome (MDS).
The global Decitabine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Decitabine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Decitabine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Decitabine include Johnson & Johnson, Eli Lilly and Company, Pharmachemie B.V., Otsuka Pharmaceutical, Sandoz, Dr Reddy's Laboratories, Accord Healthcare, Sun Pharmaceutical and Cipla, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Decitabine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decitabine.
Report Scope
The Decitabine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Decitabine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decitabine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Eli Lilly and Company
Pharmachemie B.V.
Otsuka Pharmaceutical
Sandoz
Dr Reddy's Laboratories
Accord Healthcare
Sun Pharmaceutical
Cipla
Lupin
Shandong Xinshidai Pharmaceutical
Hangzhou Zhongmei Huadong Pharmaceutical
ZHENGDA Tianqing Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Lianyungang Jierui Pharmaceutical
Qilu Pharmaceutical Hainan
Lianyungang Runzhong Pharmaceutical
Segment by Type
10 Mg Dosage Forms
15 Mg Dosage Forms
25 Mg Dosage Forms
Segment by Application
Primary MDS
Secondary MDS
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Decitabine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Decitabine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Decitabine is also known as 5 - nitrogen hetero - 2 '- DNA cytosine nucleoside, 5 - n - 2' - deoxy cytidine acid, is a kind of natural 2 '- deoxy cytidine acid adenosine analogues, by inhibiting the DNA methyltransferase, reduce DNA methylation, thus inhibiting tumor cell proliferation, and prevent the occurrence of drug resistance, for the strongest known DNA methylation specific inhibitor, belongs to the S phase of cell cycle specific drugs, is suitable for the treatment of myelodysplastic syndrome (MDS).
The global Decitabine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Decitabine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Decitabine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Decitabine include Johnson & Johnson, Eli Lilly and Company, Pharmachemie B.V., Otsuka Pharmaceutical, Sandoz, Dr Reddy's Laboratories, Accord Healthcare, Sun Pharmaceutical and Cipla, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Decitabine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decitabine.
Report Scope
The Decitabine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Decitabine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decitabine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Eli Lilly and Company
Pharmachemie B.V.
Otsuka Pharmaceutical
Sandoz
Dr Reddy's Laboratories
Accord Healthcare
Sun Pharmaceutical
Cipla
Lupin
Shandong Xinshidai Pharmaceutical
Hangzhou Zhongmei Huadong Pharmaceutical
ZHENGDA Tianqing Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Lianyungang Jierui Pharmaceutical
Qilu Pharmaceutical Hainan
Lianyungang Runzhong Pharmaceutical
Segment by Type
10 Mg Dosage Forms
15 Mg Dosage Forms
25 Mg Dosage Forms
Segment by Application
Primary MDS
Secondary MDS
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Decitabine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Decitabine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Decitabine Market Overview
1.1 Product Overview and Scope of Decitabine
1.2 Decitabine Segment by Type
1.2.1 Global Decitabine Market Value Comparison by Type (2024-2030)
1.2.2 10 Mg Dosage Forms
1.2.3 15 Mg Dosage Forms
1.2.4 25 Mg Dosage Forms
1.3 Decitabine Segment by Application
1.3.1 Global Decitabine Market Value by Application: (2024-2030)
1.3.2 Primary MDS
1.3.3 Secondary MDS
1.4 Global Decitabine Market Size Estimates and Forecasts
1.4.1 Global Decitabine Revenue 2019-2030
1.4.2 Global Decitabine Sales 2019-2030
1.4.3 Global Decitabine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Decitabine Market Competition by Manufacturers
2.1 Global Decitabine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Decitabine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Decitabine Average Price by Manufacturers (2019-2024)
2.4 Global Decitabine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Decitabine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Decitabine, Product Type & Application
2.7 Decitabine Market Competitive Situation and Trends
2.7.1 Decitabine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Decitabine Players Market Share by Revenue
2.7.3 Global Decitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Decitabine Retrospective Market Scenario by Region
3.1 Global Decitabine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Decitabine Global Decitabine Sales by Region: 2019-2030
3.2.1 Global Decitabine Sales by Region: 2019-2024
3.2.2 Global Decitabine Sales by Region: 2025-2030
3.3 Global Decitabine Global Decitabine Revenue by Region: 2019-2030
3.3.1 Global Decitabine Revenue by Region: 2019-2024
3.3.2 Global Decitabine Revenue by Region: 2025-2030
3.4 North America Decitabine Market Facts & Figures by Country
3.4.1 North America Decitabine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Decitabine Sales by Country (2019-2030)
3.4.3 North America Decitabine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Decitabine Market Facts & Figures by Country
3.5.1 Europe Decitabine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Decitabine Sales by Country (2019-2030)
3.5.3 Europe Decitabine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Decitabine Market Facts & Figures by Country
3.6.1 Asia Pacific Decitabine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Decitabine Sales by Country (2019-2030)
3.6.3 Asia Pacific Decitabine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Decitabine Market Facts & Figures by Country
3.7.1 Latin America Decitabine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Decitabine Sales by Country (2019-2030)
3.7.3 Latin America Decitabine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Decitabine Market Facts & Figures by Country
3.8.1 Middle East and Africa Decitabine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Decitabine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Decitabine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Decitabine Sales by Type (2019-2030)
4.1.1 Global Decitabine Sales by Type (2019-2024)
4.1.2 Global Decitabine Sales by Type (2025-2030)
4.1.3 Global Decitabine Sales Market Share by Type (2019-2030)
4.2 Global Decitabine Revenue by Type (2019-2030)
4.2.1 Global Decitabine Revenue by Type (2019-2024)
4.2.2 Global Decitabine Revenue by Type (2025-2030)
4.2.3 Global Decitabine Revenue Market Share by Type (2019-2030)
4.3 Global Decitabine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Decitabine Sales by Application (2019-2030)
5.1.1 Global Decitabine Sales by Application (2019-2024)
5.1.2 Global Decitabine Sales by Application (2025-2030)
5.1.3 Global Decitabine Sales Market Share by Application (2019-2030)
5.2 Global Decitabine Revenue by Application (2019-2030)
5.2.1 Global Decitabine Revenue by Application (2019-2024)
5.2.2 Global Decitabine Revenue by Application (2025-2030)
5.2.3 Global Decitabine Revenue Market Share by Application (2019-2030)
5.3 Global Decitabine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Decitabine Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Eli Lilly and Company
6.2.1 Eli Lilly and Company Corporation Information
6.2.2 Eli Lilly and Company Description and Business Overview
6.2.3 Eli Lilly and Company Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly and Company Decitabine Product Portfolio
6.2.5 Eli Lilly and Company Recent Developments/Updates
6.3 Pharmachemie B.V.
6.3.1 Pharmachemie B.V. Corporation Information
6.3.2 Pharmachemie B.V. Description and Business Overview
6.3.3 Pharmachemie B.V. Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pharmachemie B.V. Decitabine Product Portfolio
6.3.5 Pharmachemie B.V. Recent Developments/Updates
6.4 Otsuka Pharmaceutical
6.4.1 Otsuka Pharmaceutical Corporation Information
6.4.2 Otsuka Pharmaceutical Description and Business Overview
6.4.3 Otsuka Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Otsuka Pharmaceutical Decitabine Product Portfolio
6.4.5 Otsuka Pharmaceutical Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Corporation Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sandoz Decitabine Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Dr Reddy's Laboratories
6.6.1 Dr Reddy's Laboratories Corporation Information
6.6.2 Dr Reddy's Laboratories Description and Business Overview
6.6.3 Dr Reddy's Laboratories Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dr Reddy's Laboratories Decitabine Product Portfolio
6.6.5 Dr Reddy's Laboratories Recent Developments/Updates
6.7 Accord Healthcare
6.6.1 Accord Healthcare Corporation Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Accord Healthcare Decitabine Product Portfolio
6.7.5 Accord Healthcare Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Corporation Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun Pharmaceutical Decitabine Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cipla Decitabine Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Lupin
6.10.1 Lupin Corporation Information
6.10.2 Lupin Description and Business Overview
6.10.3 Lupin Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lupin Decitabine Product Portfolio
6.10.5 Lupin Recent Developments/Updates
6.11 Shandong Xinshidai Pharmaceutical
6.11.1 Shandong Xinshidai Pharmaceutical Corporation Information
6.11.2 Shandong Xinshidai Pharmaceutical Decitabine Description and Business Overview
6.11.3 Shandong Xinshidai Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shandong Xinshidai Pharmaceutical Decitabine Product Portfolio
6.11.5 Shandong Xinshidai Pharmaceutical Recent Developments/Updates
6.12 Hangzhou Zhongmei Huadong Pharmaceutical
6.12.1 Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
6.12.2 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Description and Business Overview
6.12.3 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product Portfolio
6.12.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments/Updates
6.13 ZHENGDA Tianqing Pharmaceutical Group
6.13.1 ZHENGDA Tianqing Pharmaceutical Group Corporation Information
6.13.2 ZHENGDA Tianqing Pharmaceutical Group Decitabine Description and Business Overview
6.13.3 ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ZHENGDA Tianqing Pharmaceutical Group Decitabine Product Portfolio
6.13.5 ZHENGDA Tianqing Pharmaceutical Group Recent Developments/Updates
6.14 Jiangsu Aosaikang Pharmaceutical
6.14.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
6.14.2 Jiangsu Aosaikang Pharmaceutical Decitabine Description and Business Overview
6.14.3 Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jiangsu Aosaikang Pharmaceutical Decitabine Product Portfolio
6.14.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.15 Jiangsu Haosen Pharmaceutical Group
6.15.1 Jiangsu Haosen Pharmaceutical Group Corporation Information
6.15.2 Jiangsu Haosen Pharmaceutical Group Decitabine Description and Business Overview
6.15.3 Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Jiangsu Haosen Pharmaceutical Group Decitabine Product Portfolio
6.15.5 Jiangsu Haosen Pharmaceutical Group Recent Developments/Updates
6.16 Lianyungang Jierui Pharmaceutical
6.16.1 Lianyungang Jierui Pharmaceutical Corporation Information
6.16.2 Lianyungang Jierui Pharmaceutical Decitabine Description and Business Overview
6.16.3 Lianyungang Jierui Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Lianyungang Jierui Pharmaceutical Decitabine Product Portfolio
6.16.5 Lianyungang Jierui Pharmaceutical Recent Developments/Updates
6.17 Qilu Pharmaceutical Hainan
6.17.1 Qilu Pharmaceutical Hainan Corporation Information
6.17.2 Qilu Pharmaceutical Hainan Decitabine Description and Business Overview
6.17.3 Qilu Pharmaceutical Hainan Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Qilu Pharmaceutical Hainan Decitabine Product Portfolio
6.17.5 Qilu Pharmaceutical Hainan Recent Developments/Updates
6.18 Lianyungang Runzhong Pharmaceutical
6.18.1 Lianyungang Runzhong Pharmaceutical Corporation Information
6.18.2 Lianyungang Runzhong Pharmaceutical Decitabine Description and Business Overview
6.18.3 Lianyungang Runzhong Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Lianyungang Runzhong Pharmaceutical Decitabine Product Portfolio
6.18.5 Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Decitabine Industry Chain Analysis
7.2 Decitabine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Decitabine Production Mode & Process
7.4 Decitabine Sales and Marketing
7.4.1 Decitabine Sales Channels
7.4.2 Decitabine Distributors
7.5 Decitabine Customers
8 Decitabine Market Dynamics
8.1 Decitabine Industry Trends
8.2 Decitabine Market Drivers
8.3 Decitabine Market Challenges
8.4 Decitabine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Decitabine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Decitabine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Decitabine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Decitabine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Decitabine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Decitabine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Decitabine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Decitabine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Decitabine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Decitabine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Decitabine, Product Type & Application
Table 12. Global Key Manufacturers of Decitabine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Decitabine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decitabine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Decitabine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Decitabine Sales by Region (2019-2024) & (K Units)
Table 18. Global Decitabine Sales Market Share by Region (2019-2024)
Table 19. Global Decitabine Sales by Region (2025-2030) & (K Units)
Table 20. Global Decitabine Sales Market Share by Region (2025-2030)
Table 21. Global Decitabine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Decitabine Revenue Market Share by Region (2019-2024)
Table 23. Global Decitabine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Decitabine Revenue Market Share by Region (2025-2030)
Table 25. North America Decitabine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Decitabine Sales by Country (2019-2024) & (K Units)
Table 27. North America Decitabine Sales by Country (2025-2030) & (K Units)
Table 28. North America Decitabine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Decitabine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Decitabine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Decitabine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Decitabine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Decitabine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Decitabine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Decitabine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Decitabine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Decitabine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Decitabine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Decitabine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Decitabine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Decitabine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Decitabine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Decitabine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Decitabine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Decitabine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Decitabine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Decitabine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Decitabine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Decitabine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Decitabine Sales (K Units) by Type (2019-2024)
Table 51. Global Decitabine Sales (K Units) by Type (2025-2030)
Table 52. Global Decitabine Sales Market Share by Type (2019-2024)
Table 53. Global Decitabine Sales Market Share by Type (2025-2030)
Table 54. Global Decitabine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Decitabine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Decitabine Revenue Market Share by Type (2019-2024)
Table 57. Global Decitabine Revenue Market Share by Type (2025-2030)
Table 58. Global Decitabine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Decitabine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Decitabine Sales (K Units) by Application (2019-2024)
Table 61. Global Decitabine Sales (K Units) by Application (2025-2030)
Table 62. Global Decitabine Sales Market Share by Application (2019-2024)
Table 63. Global Decitabine Sales Market Share by Application (2025-2030)
Table 64. Global Decitabine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Decitabine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Decitabine Revenue Market Share by Application (2019-2024)
Table 67. Global Decitabine Revenue Market Share by Application (2025-2030)
Table 68. Global Decitabine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Decitabine Price (US$/Unit) by Application (2025-2030)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Johnson & Johnson Decitabine Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Eli Lilly and Company Corporation Information
Table 76. Eli Lilly and Company Description and Business Overview
Table 77. Eli Lilly and Company Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Eli Lilly and Company Decitabine Product
Table 79. Eli Lilly and Company Recent Developments/Updates
Table 80. Pharmachemie B.V. Corporation Information
Table 81. Pharmachemie B.V. Description and Business Overview
Table 82. Pharmachemie B.V. Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Pharmachemie B.V. Decitabine Product
Table 84. Pharmachemie B.V. Recent Developments/Updates
Table 85. Otsuka Pharmaceutical Corporation Information
Table 86. Otsuka Pharmaceutical Description and Business Overview
Table 87. Otsuka Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Otsuka Pharmaceutical Decitabine Product
Table 89. Otsuka Pharmaceutical Recent Developments/Updates
Table 90. Sandoz Corporation Information
Table 91. Sandoz Description and Business Overview
Table 92. Sandoz Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sandoz Decitabine Product
Table 94. Sandoz Recent Developments/Updates
Table 95. Dr Reddy's Laboratories Corporation Information
Table 96. Dr Reddy's Laboratories Description and Business Overview
Table 97. Dr Reddy's Laboratories Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Dr Reddy's Laboratories Decitabine Product
Table 99. Dr Reddy's Laboratories Recent Developments/Updates
Table 100. Accord Healthcare Corporation Information
Table 101. Accord Healthcare Description and Business Overview
Table 102. Accord Healthcare Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Accord Healthcare Decitabine Product
Table 104. Accord Healthcare Recent Developments/Updates
Table 105. Sun Pharmaceutical Corporation Information
Table 106. Sun Pharmaceutical Description and Business Overview
Table 107. Sun Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sun Pharmaceutical Decitabine Product
Table 109. Sun Pharmaceutical Recent Developments/Updates
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Cipla Decitabine Product
Table 114. Cipla Recent Developments/Updates
Table 115. Lupin Corporation Information
Table 116. Lupin Description and Business Overview
Table 117. Lupin Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Lupin Decitabine Product
Table 119. Lupin Recent Developments/Updates
Table 120. Shandong Xinshidai Pharmaceutical Corporation Information
Table 121. Shandong Xinshidai Pharmaceutical Description and Business Overview
Table 122. Shandong Xinshidai Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Shandong Xinshidai Pharmaceutical Decitabine Product
Table 124. Shandong Xinshidai Pharmaceutical Recent Developments/Updates
Table 125. Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
Table 126. Hangzhou Zhongmei Huadong Pharmaceutical Description and Business Overview
Table 127. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product
Table 129. Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments/Updates
Table 130. ZHENGDA Tianqing Pharmaceutical Group Corporation Information
Table 131. ZHENGDA Tianqing Pharmaceutical Group Description and Business Overview
Table 132. ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. ZHENGDA Tianqing Pharmaceutical Group Decitabine Product
Table 134. ZHENGDA Tianqing Pharmaceutical Group Recent Developments/Updates
Table 135. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 136. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 137. Jiangsu Aosaikang Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Jiangsu Aosaikang Pharmaceutical Decitabine Product
Table 139. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 140. Jiangsu Haosen Pharmaceutical Group Corporation Information
Table 141. Jiangsu Haosen Pharmaceutical Group Description and Business Overview
Table 142. Jiangsu Haosen Pharmaceutical Group Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Jiangsu Haosen Pharmaceutical Group Decitabine Product
Table 144. Jiangsu Haosen Pharmaceutical Group Recent Developments/Updates
Table 145. Lianyungang Jierui Pharmaceutical Corporation Information
Table 146. Lianyungang Jierui Pharmaceutical Description and Business Overview
Table 147. Lianyungang Jierui Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Lianyungang Jierui Pharmaceutical Decitabine Product
Table 149. Lianyungang Jierui Pharmaceutical Recent Developments/Updates
Table 150. Qilu Pharmaceutical Hainan Corporation Information
Table 151. Qilu Pharmaceutical Hainan Description and Business Overview
Table 152. Qilu Pharmaceutical Hainan Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Qilu Pharmaceutical Hainan Decitabine Product
Table 154. Qilu Pharmaceutical Hainan Recent Developments/Updates
Table 155. Lianyungang Runzhong Pharmaceutical Corporation Information
Table 156. Lianyungang Runzhong Pharmaceutical Description and Business Overview
Table 157. Lianyungang Runzhong Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Lianyungang Runzhong Pharmaceutical Decitabine Product
Table 159. Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Decitabine Distributors List
Table 163. Decitabine Customers List
Table 164. Decitabine Market Trends
Table 165. Decitabine Market Drivers
Table 166. Decitabine Market Challenges
Table 167. Decitabine Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Decitabine
Figure 2. Global Decitabine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Decitabine Market Share by Type in 2023 & 2030
Figure 4. 10 Mg Dosage Forms Product Picture
Figure 5. 15 Mg Dosage Forms Product Picture
Figure 6. 25 Mg Dosage Forms Product Picture
Figure 7. Global Decitabine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Decitabine Market Share by Application in 2023 & 2030
Figure 9. Primary MDS
Figure 10. Secondary MDS
Figure 11. Global Decitabine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Decitabine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Decitabine Sales (2019-2030) & (K Units)
Figure 14. Global Decitabine Average Price (US$/Unit) & (2019-2030)
Figure 15. Decitabine Report Years Considered
Figure 16. Decitabine Sales Share by Manufacturers in 2023
Figure 17. Global Decitabine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Decitabine Players: Market Share by Revenue in 2023
Figure 19. Decitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Decitabine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Decitabine Sales Market Share by Country (2019-2030)
Figure 22. North America Decitabine Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Decitabine Sales Market Share by Country (2019-2030)
Figure 26. Europe Decitabine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Decitabine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Decitabine Revenue Market Share by Region (2019-2030)
Figure 34. China Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Decitabine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Decitabine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Decitabine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Decitabine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Decitabine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Decitabine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Decitabine by Type (2019-2030)
Figure 56. Global Decitabine Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Decitabine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Decitabine by Application (2019-2030)
Figure 59. Global Decitabine Price (US$/Unit) by Application (2019-2030)
Figure 60. Decitabine Value Chain
Figure 61. Decitabine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
